oral semaglutide launch Novo Nordisk has received FDA approval for Wegovy® (semaglutide) 25 mg, taken once daily, making it the first oral GLP-1 drug approved for obesity. Based on OASIS and SELECT trials, it Oral semaglutide weight loss vs

Mazdutide and Retatrutide are research compounds Understanding "Dual Agonist" Terminology Both Mazdutide and Tirzepatide are classified as "dual agonists"but this terminology obscures a critical difference

The 9 Best Peptide Clinics in Dallas-Fort Worth (2026) Verified & Reviewed Best Peptide Clinics in Dallas-Fort Worth Peptide therapy has moved from niche longevity circles into mainstream Dallas-Fort Worth medicine over the past two years, driven by GLP-1 weight-loss demand and the April 2026 FDA reclassification of previously-restricted peptides including BPC-157 and TB-500

Peptide therapy isnt a one-and-done decision

Why Shot Day Eating Matters on GLP-1 GLP-1 shot day meals matter because shot day can change how food feels

Discontinue if pancreatitis is suspected